SV EN

Donor metabolic characteristics drive effects of faecal microbiota transplantation...

02 March 2020

This article, published in the March issue of Gut, concludes that allogenic FMT using METS-D decreases insulin sensitivity in metabolic syndrome recipients when compared with using post-RYGB-D. Further research is needed to delineate the role of donor characteristics in FMT efficacy in human insulin-resistant subjects.

Read the article in Gut
Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time

This site uses cookies, by continuing you agree to the use of cookies